Benzinga
Benzinga
Actualités France
Bourse
Economie
Général
Actualités Américaines
Bourse
Bénéfices
Economie
Marchés prédictifs
Marchés privés
Autres marchés
Recommandations des analystes
Trading
Communiqués de presse
Mondial
Asie
Crypto-monnaies
Actualités cryptos
Altcoins
Bitcoin
Dogecoin
Ethereum
Shiba Inu
NFT
Éducation
Investir en crypto
Investir en bourse
Forex
Benzinga
jeudi, octobre 15
Actualités France
Bourse
Economie
Général
Actualités Américaines
Bourse
Bénéfices
Economie
Marchés prédictifs
Marchés privés
Autres marchés
Recommandations des analystes
Trading
Communiqués de presse
Mondial
Asie
Crypto-monnaies
Actualités cryptos
Altcoins
Bitcoin
Dogecoin
Ethereum
Shiba Inu
NFT
Éducation
Investir en crypto
Investir en bourse
Forex
SkinHealth Systems Inc
SKIN
NASDAQ
Liste de surveillance
Get Report
Trade with Public
Get Report
Trade with Public
$10.71
-0.86
-7.4%
Dern. MÀJ: Oct 15, 9:42 AM
$11.20
-0.36
-3.11%
Get Report
Aperçu
Actualités
Prévisions de résultats
Événements
Objectifs de cours
Données financières
Sentiment
Actionnariat
Comparer
Options
Rapport sur les stocks
Privacy Manager
Fractionnement d'actions:
SkinHealth Systems Inc s'est récemment scindé Wednesday, October 14, 2026 avec un ratio de 1:20
SkinHealth Systems Financials
SkinHealth Systems (SKIN) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
PRO
Beauty Health Sees Q3 Sales $65.000M-$70.000M vs $69.220M Est
Beauty Health (NASDAQ:SKIN) sees Q3 sales of $65.000 million-$70.000 million vs $69.220 million analyst estimate.
Benzinga Newsdesk
PRO
Beauty Health Narrows FY2026 Sales Guidance from $280.000M-$295.000M to $280.000M-$290.000M vs $289.529M Est
Beauty Health (NASDAQ:SKIN) narrows FY2026 sales outlook from $280.000 million-$295.000 million to $280.000 million-$290.000 million vs $289.529 million estimate.
Benzinga Newsdesk
PRO
Beauty Health Q2 EPS $(0.02), Inline, Sales $72.100M Miss $74.294M Estimate
Beauty Health (NASDAQ:SKIN) reported quarterly losses of $(0.02) per share which met the analyst consensus estimate. This is a 166.67 percent decrease over earnings of $0.03 per share from the same period last year.
Benzinga Newsdesk
PRO
Beauty Health Sees Q2 Sales $72.000M-$77.000M vs $76.764M Est
Beauty Health (NASDAQ:SKIN) sees Q2 sales of $72.000 million-$77.000 million vs $76.764 million analyst estimate.
Benzinga Newsdesk
PRO
Beauty Health Lowers FY2026 Sales Guidance from $285.000M-$305.000M to $280.000M-$295.000M vs $297.498M Est
Beauty Health (NASDAQ:SKIN) lowers FY2026 sales outlook from $285.000 million-$305.000 million to $280.000 million-$295.000 million vs $297.498 million estimate.
Benzinga Newsdesk
PRO
Beauty Health Q1 EPS $(0.05) Beats $(0.07) Estimate, Sales $64.900M Miss $66.448M Estimate
Beauty Health (NASDAQ:SKIN) reported quarterly losses of $(0.05) per share which beat the analyst consensus estimate of $(0.07) by 28.57 percent. This is a 37.5 percent increase over losses of $(0.08) per share from the
Benzinga Newsdesk
